ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio
July 12, 2021ProfoundBio announced the closing of a $55+ million Series A financing round led by Lilly Asia Venture and co-led by LYFE Capital, with participation from Sequoia Capital China and Oriza. -
Neurophth Closes RMB 400 Million Series B Financing
February 10, 2021Neurophth Biotechnology Ltd. announced the closing of a RMB 400 million ($61.9 million USD) Series-B financing with a premier syndicate of investors, co-led by Guofang Capital and InnoVision Capital.
Pharma Sources Insight January 2025
